Literature DB >> 20313798

Interaction between immunologic and chemotherapeutic treatments.

P W Mullen.   

Abstract

Year:  1982        PMID: 20313798      PMCID: PMC1862160     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum.

Authors:  L F Soyka; W G Hunt; S E Knight; R S Foster
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

2.  Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents.

Authors:  K W Renton; G J Mannering
Journal:  Biochem Biophys Res Commun       Date:  1976-11-22       Impact factor: 3.575

3.  The metabolism of drugs in isolated rat hepatocytes. A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions.

Authors:  R E Billings; R E McMahon; J Ashmore; S R Wagle
Journal:  Drug Metab Dispos       Date:  1977 Nov-Dec       Impact factor: 3.922

4.  Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.

Authors:  P W Mullen; R W Foster
Journal:  J Pharm Pharmacol       Date:  1979-02       Impact factor: 3.765

5.  Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment.

Authors:  D Farquhar; T L Loo; J U Gutterman; E M Hersh; M A Luna
Journal:  Biochem Pharmacol       Date:  1976-07-01       Impact factor: 5.858

6.  Decreased elimination of theophylline after influenza vaccination.

Authors:  K W Renton; J D Gray; R I Hall
Journal:  Can Med Assoc J       Date:  1980-08-23       Impact factor: 8.262

7.  Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.

Authors:  H H Wan; N Thatcher; P W Mullen; G N Smith; P M Wilkinson
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.